A R Haug

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi [Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Klinikum der Ludwigs Maximilians Universität München, Campus Grosshadern, Marchioninistr 15, 81377, Munchen, Deutschland
    Radiologe 50:349-54. 2010
  2. ncbi 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:371-7. 2012
  3. ncbi [Gastroenteropancreatic neuroendocrine tumors: diagnosis and therapy in nuclear medicine]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Universitätsklinikum der Ludwig Maximilians Universität München, Marchioninistrasse 15, Munich, Germany
    Internist (Berl) 53:161-6. 2012
  4. ncbi F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers
    Alexander Robert Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Germany
    J Comput Assist Tomogr 31:629-34. 2007
  5. ncbi Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
    Alexander Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 36:765-70. 2009
  6. ncbi 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 51:1349-56. 2010
  7. ncbi 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 38:1037-45. 2011
  8. ncbi Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 52:1679-83. 2011
  9. ncbi [Hepatic metastases in CUP (cancer of unknown primary) and painful amaurosis]
    A Klingenstein
    Augenklinik, Ludwig Maximilians Universitat Munchen, Mathildenstraße 8, 80336, Munchen, Deutschland
    Ophthalmologe 107:947-50. 2010

Detail Information

Publications9

  1. ncbi [Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Klinikum der Ludwigs Maximilians Universität München, Campus Grosshadern, Marchioninistr 15, 81377, Munchen, Deutschland
    Radiologe 50:349-54. 2010
    ..The immunohistochemical expression of somatostatin receptor (SSTR) subtype 2 was compared to quantitative (68)Ga-DOTATATE PET in neuroendocrine tumors (NET)...
  2. ncbi 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:371-7. 2012
    ..The objective of the present study was to evaluate (18)F-FDG PET/CT for predicting survival in these patients...
  3. ncbi [Gastroenteropancreatic neuroendocrine tumors: diagnosis and therapy in nuclear medicine]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Universitätsklinikum der Ludwig Maximilians Universität München, Marchioninistrasse 15, Munich, Germany
    Internist (Berl) 53:161-6. 2012
    ..Up to 46% of patients suffering from GEP-NET show a response to this therapy, which is able to mitigate tumour-related symptoms and significantly improve quality of life...
  4. ncbi F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers
    Alexander Robert Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Germany
    J Comput Assist Tomogr 31:629-34. 2007
    ..The value of combined positron emission tomography (PET)/computed tomography (CT) in the follow-up of patients with breast cancer with elevated tumor markers but without proven metastases or local recurrence was assessed...
  5. ncbi Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
    Alexander Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 36:765-70. 2009
    ..To compare the diagnostic impact of (68)Ga-DOTA-TATE and (18)F-DOPA PET in the diagnosis of well-differentiated metastatic neuroendocrine tumours (NET)...
  6. ncbi 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 51:1349-56. 2010
    ....
  7. ncbi 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 38:1037-45. 2011
    ..We aimed to evaluate the prognostic power of FDG PET/CT and that of pretherapeutic scintigraphy with (99m)Tc-labelled macroagglutinated albumin (MAA), an index of tumour vascularization...
  8. ncbi Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 52:1679-83. 2011
    ..We hypothesized that (68)Ga-DOTATATE uptake of neuroendocrine tumors is sensitive to therapy with a nonradioactive somatostatin analog...
  9. ncbi [Hepatic metastases in CUP (cancer of unknown primary) and painful amaurosis]
    A Klingenstein
    Augenklinik, Ludwig Maximilians Universitat Munchen, Mathildenstraße 8, 80336, Munchen, Deutschland
    Ophthalmologe 107:947-50. 2010
    ..FDG-PET/CT was able to successfully align hepatic metastases due to CUP with local ophthalmologic diagnostic findings and led to a correct diagnosis...